by Kaustubh Bagalkote | Jul 13, 2026 | General
Earnings season kicks into high gear next week, with a slate of heavyweight companies set to report quarterly results between July 12 and July 18. As investors look for fresh insight into corporate earnings, guidance and the broader economic backdrop, options traders...
by Avi Kapoor | Jul 13, 2026 | General
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Keefe, Bruyette & Woods analyst Ryan Tomasello downgraded...
by Dylan Berman | Jul 13, 2026 | General
Merck & Co. Inc. (NYSE:MRK) shares are in focus Monday after a wave of analyst activity capped by a new FDA approval for its cancer drug Keytruda. Merck stock is trading near recent highs. What’s the outlook for MRK shares? Analyst Consensus and Recent Actions The...
by Vandana Singh | Jul 13, 2026 | General
GSK plc (NYSE:GSK) on Monday reported interim results from its registrational Phase 2 AZUR-1 trial of Jemperli (dostarlimab) in rectal cancer patients. The data showed that its immunotherapy Jemperli achieved a meaningful and sustained clinical complete response at 12...
by Avi Kapoor | Jul 13, 2026 | General
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. JP Morgan raised the price target for Capital One Financial Corp (NYSE:COF)...
Recent Comments